These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 2126373

  • 1. Imaging of inflammatory bowel disease (IBD) and scintigraphic assessment of resected colon: comparison of 111 In-oxine and 99mTC HMPAO leucocyte labelling.
    Moisan A, Lecloirec J, Bretagne JF, Loreal O, Raoul JL, Herry JY.
    Prog Clin Biol Res; 1990; 355():159-64. PubMed ID: 2126373
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of simultaneous 99mTc-HMPAO and 111In oxine labelled white cell scans in the assessment of inflammatory bowel disease.
    Allan RA, Sladen GE, Bassingham S, Lazarus C, Clarke SE, Fogelman I.
    Eur J Nucl Med; 1993 Mar; 20(3):195-200. PubMed ID: 8462606
    [Abstract] [Full Text] [Related]

  • 3. Leucocyte radiolabelling techniques: practical aspects.
    Frier M.
    Scand J Gastroenterol Suppl; 1994 Mar; 203():32-5. PubMed ID: 7973446
    [Abstract] [Full Text] [Related]

  • 4. Quantitative assessment of overall inflammatory bowel disease activity using labelled leucocytes: a direct comparison between indium-111 and technetium-99m HMPAO methods.
    Mansfield JC, Giaffer MH, Tindale WB, Holdsworth CD.
    Gut; 1995 Nov; 37(5):679-83. PubMed ID: 8549945
    [Abstract] [Full Text] [Related]

  • 5. Antigranulocyte monoclonal antibody (Ab) 250/183. Normal kinetics and clinical experience.
    Roca M, Moragas M, Daumal J, Piera C, Martin-Comin J, Lomeña F, Ramos M, Setoain J.
    Prog Clin Biol Res; 1990 Nov; 355():311-8. PubMed ID: 2126378
    [No Abstract] [Full Text] [Related]

  • 6. Labelled leukocytes for diagnosis of infectious diseases. Our experience in labelling and clinical usefulness.
    Tagliabue L, Majoli C, Pajoro U, Musarra M, Di Leo C, Del Sole A, Bestetti A, Tarolo GL.
    Minerva Med; 2000 Nov; 91(11-12):267-74. PubMed ID: 11253707
    [Abstract] [Full Text] [Related]

  • 7. 99Tcm and 111In leucocyte scintigraphy in inflammatory bowel disease.
    Li DJ, Middleton SJ, Wraight EP.
    Nucl Med Commun; 1992 Dec; 13(12):867-70. PubMed ID: 1465269
    [Abstract] [Full Text] [Related]

  • 8. Value of technetium-99m HMPAO-labelled leucocyte scintigraphy as an initial screening test in patients suspected of having inflammatory bowel disease.
    Giaffer MH, Tindale WB, Holdsworth D.
    Eur J Gastroenterol Hepatol; 1996 Dec; 8(12):1195-200. PubMed ID: 8980940
    [Abstract] [Full Text] [Related]

  • 9. Comparison of technetium-99m-HM-PAO leukocytes with indium-111-oxine leukocytes for localizing intraabdominal sepsis.
    Mountford PJ, Kettle AG, O'Doherty MJ, Coakley AJ.
    J Nucl Med; 1990 Mar; 31(3):311-5. PubMed ID: 2106576
    [Abstract] [Full Text] [Related]

  • 10. Thrombocytes labelled with 99mTc-HMPAO in vitro studies and preliminary clinical experience.
    Hardeman MR.
    Prog Clin Biol Res; 1990 Mar; 355():49-54. PubMed ID: 2149183
    [No Abstract] [Full Text] [Related]

  • 11. Kinetic of Tc-99m-anti-NCA-95-Moab in vitro labelled granulocytes in comparison to in-vivo Moab-labelled and In-111-oxine-labelled granulocytes.
    Becker W, Marienhagen J, Ordnung D, Wolf F.
    Prog Clin Biol Res; 1990 Mar; 355():151-8. PubMed ID: 2126372
    [No Abstract] [Full Text] [Related]

  • 12. Inflammatory bowel disease activity assessment using technetium-99m-HMPAO leukocytes.
    Arndt JW, Grootscholten MI, van Hogezand RA, Griffioen G, Lamers CB, Pauwels EK.
    Dig Dis Sci; 1997 Feb; 42(2):387-93. PubMed ID: 9052524
    [Abstract] [Full Text] [Related]

  • 13. Inflammatory bowel disease examination with 99mTc-HMPAO labelled leucocytes scintigraphy.
    Martin-Comin J, Moragas M, Daumal J, Lomena F, Roca M, Catafau A, Prat L, Bonnin D, Piera C.
    Prog Clin Biol Res; 1990 Feb; 355():165-72. PubMed ID: 2281096
    [No Abstract] [Full Text] [Related]

  • 14. Is it possible to assess disease activity of inflammatory bowel disease with scintigraphy?
    Arndt JW, Grootscholten MI.
    Neth J Med; 1996 Feb; 48(2):49-52. PubMed ID: 8819798
    [Abstract] [Full Text] [Related]

  • 15. Technetium-99m hexamethyl propylene amine oxine leucocytes in the assessment of disease activity in inflammatory bowel disease.
    Lantto E, Järvi K, Krekelä I, Lantto T, Taavitsainen M, Vedenkangas H, Vorne M.
    Eur J Nucl Med; 1992 Feb; 19(1):14-8. PubMed ID: 1547802
    [Abstract] [Full Text] [Related]

  • 16. Abdominal scintigraphy using 99mTc-HMPAO-labelled leucocytes in patients with seronegative spondylarthropathies without clinical evidence of inflammatory bowel disease.
    Alonso JC, Lopez-Longo FJ, Lampreave JL, González CM, Vegazo O, Carreño L, Almoguera I.
    Eur J Nucl Med; 1996 Mar; 23(3):243-6. PubMed ID: 8599954
    [Abstract] [Full Text] [Related]

  • 17. The significance of low grade right iliac fossa uptake on 99Tcm-HMPAO labelled white cell scans.
    Small JH, Wraight EP, Freeman AH, Miles KA.
    Br J Radiol; 1996 Oct; 69(826):914-9. PubMed ID: 9038526
    [Abstract] [Full Text] [Related]

  • 18. Labelled leucocyte scintigraphy in inflammatory bowel disease: clinical applications.
    Giaffer MH.
    Gut; 1996 Jan; 38(1):1-5. PubMed ID: 8566834
    [No Abstract] [Full Text] [Related]

  • 19. 99mTc-labelled anti NCA-95 antibodies in prosthetic heart valve endocarditis.
    Bair HJ, Becker W, Volkholz HJ, Wolf F.
    Nuklearmedizin; 1991 Aug; 30(4):149-50. PubMed ID: 1788081
    [Abstract] [Full Text] [Related]

  • 20. Comparison of three different methods for radiolabelling human activated T lymphocytes.
    Botti C, Negri DR, Seregni E, Ramakrishna V, Arienti F, Maffioli L, Lombardo C, Bogni A, Pascali C, Crippa F, Massaron S, Remonti F, Nerini-Molteni S, Canevari S, Bombardieri E.
    Eur J Nucl Med; 1997 May; 24(5):497-504. PubMed ID: 9142729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.